[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients].
Sun AN, Tian XP, Cao XS, Ouyang J, Gu J, Xu KL, Yu K, Zeng QS, Sun ZM, Chen GA, Gao SJ, Zhou J, Wang JH, Yang LH, Luo JM, Zhang M, Guo XH, Wang XM, Zhang X, Shi KQ, Sun H, Ding XM, Hu JD, Zheng RJ, Zhao HG, Hou M, Wang X, Chen FP, Zhu Y, Liu H, Huang DP, Liao AJ, Ma LM, Su LP, Liu L, Zhou ZP, Huang XB, Sun XM, Wu DP.
Sun AN, et al. Among authors: zhao hg.
Zhonghua Xue Ye Xue Za Zhi. 2017 Dec 14;38(12):1017-1023. doi: 10.3760/cma.j.issn.0253-2727.2017.12.003.
Zhonghua Xue Ye Xue Za Zhi. 2017.
PMID: 29365393
Free PMC article.
Chinese.